Conference themes Returning for its second year, the virtual Epigenetic Therapeutic Targets Summit is the first-ever industry forum dedicated exclusively to the frontier of drug development in epigenetics.
The two-day program will enable you to:
Explore the full spectrum oncological and non-oncological applications of genetic regulation therapeutics that is being investigated to identify new unmet clinical needs that epigenetics could be central to treating.
Speakers: Ellen Filvaroff, Executive Director in Translational Development, Bristol-Myers Squibb, Elisabetta Chiarparin, Director - Medicinal Chemistry, AstraZeneca and more